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siRNA KNOCKDOWN OF SPHK1 IN VIVO PROTECTS MICE FROM 
SYSTEMIC, TYPE-I ALLERGY
J. Manikandan, PN Pushparaj, and AJ. Melendez
Molecular and Cellular Immunology Laboratory
Systemic anaphylaxis is considered to be a typical immediate 
hypersensitivity response, determined by the activation of immune cells, 
via antigen-induced aggregation of IgE-sensitized FcεRI cells. Perhaps 
most the important cells, in the immediate hypersensitivity responses, are 
mast cells. We have previously shown that SPHK1 plays a key role in the 
intracellular signaling pathways triggered by FceRI aggregation on human 
mast cells. More recently, we performed a genome-wide gene expression 
profiling of human mast cells, sensitized with IgE alone, or stimulated by 
FcεRI aggregation.  We found that sphingosine kinase 1 (SPHK1) was one 
of genes activated at the earlier stages of mast cell activation, including 
during sensitization. Moreover, SPHK1 has been shown, by us and others, 
to be a key player in the intracellular signaling pathways triggered by 
several immune-receptors, including fMLP, C5a, and Fcg- and Fce-
receptors. 
Here we have investigated the in vivo role of SPHK1 in allergy, using a 
specific siRNA to knockdown SPHK1 in vivo. Our results support a role for 
SPHK1 in the inflammatory responses that share clinical, immunological, 
and histological features of type I hypersensitivity. Thus, mice pretreated 
with the siRNA for SPHK1 were protected from the IgE mediated allergic 
reactions including: temperature changes, histamine release, cytokine 
production, cell-adhesion molecule expression, and immune cell infiltration 
into the lungs.
INTRODUCTION
MATERIALS AND METHODS
Animals
All experiments were performed on male BALB/c mice, aged 6-10 weeks obtained from the 
Laboratory Animal Holding Unit, National University of Singapore, Singapore. 
SPHK 1- siRNA
The specific siRNA for SPHK 1 sequence, 5’-GGGCAAGGCUCUGCAGCUCdTT-3’ (sense) and 
5’GAGCUGCAGAGCCUUGCCCdTT-3’(antisense); The annealed double-stranded lyophilized 
SPHK 1 siRNA (Qiagen Inc., CA, USA), was dissolved in the siRNA suspension buffer to obtain 20 
µM solutions. The tubes were heated to 90°C for 1 min and incubated at 37°C for 60 min. Then the 
siRNAs were diluted accordingly to obtain the required concentration for the experiments. 
Induction of Passive Systemic Anaphylaxis
BALB/c mice were lightly anesthetized and administered intravenously through the tail vein with 
20µg of monoclonal mouse anti-DNP IgE diluted in 200 µl of PBS. The positive control group was 
administered i.v. injection of 1mg of DNP-BSA in 100 µl of PBS after 24h of anti-DNP IgE
administration. Control mice received IgE alone or DNP alone in PBS. The treatment groups 
received (i.v.) with 4µg of siRNA for SPHK1 in 200ml PBS  at 0h, 24h and 48h prior to IgE
administration.
Monitoring of Rectal Temperature
Changes in core body temperature associated with systemic anaphylaxis were monitored by 
measuring changes in rectal temperature using a rectal probe coupled to a digital thermometer.
Histological study
Samples of lung were obtained, fixed in 10% neutral buffered formalin, paraplast-embedded, cut into 
5 mm sections and stained with hematoxylin-eosin according to standard procedures.
Immunohistochemistry
Immunohistochemistry was used to examine the expression of P-selectin, VCAM-1 and ICAM-1. 
RESULTS
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Fig 2.Assessment of rectal temperature during 
IgE-mediated  systemic anaphylaxis
The monitoring of rectal temperature was started at the time of 
antigen injection. siRNA injected mice were administered with 4mg 
i.v at 0hr, 24hr and 48hr prior to antigen challenge. Data are shown 
as mean ± SD. * P<0.05. Five animals were used in each 
experimental condition.
Histologic Assessment of Lung Tissue
Fig 3. Hematoxylin and Eosin staining
RT-PCR (A & B) and Western blot (C &D) showing the knockdown of murine 
SPHK 1 in PBMNCs by repetitive administration of SPHK 1 specific siRNA (4 
µg and 8 µg) i.v. (0.2 ml/min) at 0 hr, 24 hr, and 48 hr respectively within 1 
minute in male BALB/c mice (n=5). 
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Fig1. RT-PCR and Western blot for the expression of 
mouse SPHK 1 in PBMNCs.
Sections of formalin-fixed lung tissue from a WT control mouse(A) 
and IgE+DNP-BSA triggered (B, C) siRNA (SPHK1)+ IgE+DNP-BSA 
(D) were stained with hematoxylin and eosin before examination by 
light microscopy. Lung sections from IgE+DNP-BSA  triggered  mice 
revealed the presence of inflammatory cells in the subepithelium of 
conducting airways (B), around blood vessels (B) and parenchyma 
(C) which was not seen in sections from WT mice (A) and siRNA
treated (D). 
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Sections of formalin-fixed lung tissue from a WT control mouse (A, B) 
and IgE+DNP-BSA triggered (C, D) siRNA (SPHK1)+ IgE+DNP-BSA 
(E, F) were stained with toluidine blue before examination by light 
microscopy. Lung sections from IgE+DNP-BSA triggered mice 
revealed the presence dark blue–stained mast cell granules (arrows) 
in the blood vessels (C), parenchyma (D). Mast cells were not seen 
section from WT (A, B) and SiRNA treated (E, F).
Characterization of immune cells
Fig 4. Toluidine blue staining
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Immunohistochemical detection of Cell Adhesion 
Molecules
Fig 5. P-Selectin
Immonofluorescence of lungs from mice showing the expression of P-
selectin in the IgE+DNP-BSA (green arrows) treated mice (C, D) around 
the airway epithelium, which was not observed in WT(A, B) and siRNA
(white arrows) treated mice (E, F). 
Fig 6. VCAM1
Immonofluorescence of lungs from mice showing the expression of 
VCAM1 in the IgE+DNP-BSA treated mice (C,D) around the airway 
epithelium (red arrows) and epithelium (violet arrows), which was not 
observed in WT(A, B) and siRNA (white arrows) treated mice (E, F).
Fig 7. ICAM1
Immonofluorescence of lungs from mice showing the expression of 
ICAM1 in the IgE+DNP-BSA treated mice (C, D) around the airway 
epithelium (white arrows) and endothelium (green arrows), which was 
not observed in WT (A, B) and siRNA treated mice (E, F).
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Repetitive administration of siRNA targets SPHK 1 in PBMNCs and 
significantly causes the reduction in SPHK 1 mRNA levels. 
IgE mediated systemic anaphylaxis was significantly enhanced in 
mice as assessed by changes in rectal temperature.
Histological studies revealed that immune cell infiltration and 
characterization.
The overall inflammatory cascade and resulting migratory response 
of immune cells were significantly altered by the knock down of Sphk1.
Promising therapeutic potential for compounds that inhibit SPHK1 to 
treat type-I allergy and other pathological conditions.
This work was supported by a
N
a
t
u
r
e
 
P
r
e
c
e
d
i
n
g
s
 
:
 
d
o
i
:
1
0
.
1
0
3
8
/
n
p
r
e
.
2
0
0
7
.
1
1
4
7
.
1
 
:
 
P
o
s
t
e
d
 
2
7
 
S
e
p
 
2
0
0
7
